GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited Standalone and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics has informed BSE that its Board of Directors will meet on November 14, 2025, at the registered office in Mapusa, Goa. The agenda includes considering and approving the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025 (Q2 and H1 of FY26). The trading window for designated persons had been closed from October 1, 2025, and will reopen 48 hours after the results are filed with the stock exchange. The notice has been circulated to all directors and designated employees.
This is a routine regulatory intimation and contains no financial data. Investors should wait for the actual Q2/H1 results on or after November 14 to assess earnings performance, margins, and outlook for the stock.